In spite of major medical advances in heart transplant patients, psychiatric comorbidity remains very high in pre-and post-transplant phases. Anxiety and depression are especially frequent. They impact significantly morbidity and mortality. Especially because they are associated with poor therapeutic adherence and risks of infection and rejection. The inability to make beneficial therapeutic choice can be explained by the negative perception of events, associated with anxio-depressive disorders. This results in an important deterioration in quality of life of patients. The investigators assume that better management of emotions might reduce the stress of waiting situation and its psychopathological and somatic consequences pre-and post-transplant.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
60
Service de Psychiatrie d'Adultes Liaison/Consultation,
Bron, France
RECRUITINGPôle de Psychiatrie et de Neurologie
Grenoble, France
NOT_YET_RECRUITINGEvaluation of the impact of a psychotherapeutic intervention on the quality of life of cardiac transplant patients.
The quality of life is assessed with the MLHFQ - Minnesota Living with Heart Failure Questionnaire.
Time frame: The quality of life is evaluated before the cardiac transplantation and during the 12 months after the cardiac transplantation.
Anxiety manifestations pre-and post-transplant
Anxiety manifestations pre-and post-transplant measured with the State-Trait Anxiety Inventory
Time frame: Before the cardiac transplantation and during 12 months after the cardiac transplantation
Depressive symptoms pre-and post-transplant
depressive symptoms pre-and post-transplant measured using the Beck Depression Inventory (BDI-II)
Time frame: Before the cardiac transplantation and during 12 months after the cardiac transplantation
Pre and post-transplant major clinical events
Time frame: Before the cardiac transplantation and during 12 months after the cardiac transplantation
Hospitalization modalities around the graft
by measuring the duration of stay in hospital, number of surgery necessary
Time frame: Before the cardiac transplantation and during 12 months after the cardiac transplantation
Somatic complications after the heart transplantation
by measuring the mortality rate and number of graft rejection
Time frame: During 12 months after the cardiac transplantation
The therapeutic adherence pre-and post-transplant
using an adherence questionnaire
Time frame: Before the cardiac transplantation and during 12 months after the cardiac transplantation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.